Last reviewed · How we verify
NCT05176015
Nystagmus Assessment for Patients Consulting in the Emergency Department for Acute Vertigo
NA trial testing Frenzel Lens in Nystagmus, Acquired in 120 participants. Completed in 10 February 2025.
10 February 2025
Quick facts
| Lead sponsor | CHU de Quebec-Universite Laval |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | diagnostic |
| Enrollment | 120 |
| Start date | 15 January 2022 |
| Primary completion | 10 February 2025 |
| Estimated completion | 10 February 2025 |
| Sites | 5 locations across Canada |
Drugs / interventions tested
- Frenzel Lens
- Diagnostic Algorithm
Conditions studied
- Nystagmus, Acquired — all drugs for Nystagmus, Acquired →
- Stroke, Acute — all drugs for Stroke, Acute →
Sponsor
CHU de Quebec-Universite Laval — full company profile →
Who can join
Adults 18 to 100, any sex, with Nystagmus, Acquired or Stroke, Acute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot study is perfomed to validate and document faisability of the use of Frenzel lens and the use of a diagnostic algorithm for the assessment of a special sign (nystagmus) observe in the eyes of patients consulting in the emergency department (ED) for an acute episode of vertigo/dizziness/imbalance.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Human retinal secretome: A cross-link between mesenchymal and retinal cells.
Donato L, Scimone C, Alibrandi S, Scalinci SZ, et al · · 2023 · cited 6× · PMID 37545752 · DOI 10.4252/wjsc.v15.i7.665 -
Integrated diagnostic algorithm for acute vertigo combining TiTrATE, STANDING, and HINTS: a validation study in the emergency department.
Cortese E, Rochelle P, Patel F, Koohi N, et al · · 2025 · cited 1× · PMID 40659780 · DOI 10.1038/s41598-025-11007-9
Verify or expand the search:
- PubMed search for NCT05176015
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other CHU de Quebec-Universite Laval trials
Trials by the same sponsor.
- NCT07067827 — Self-questionnaire in Osteoporosis · recruiting
- NCT06018116 — A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer. · Phase 2 · withdrawn
- NCT05941806 — Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection · Phase 3 · unknown
- NCT06351176 — Impact of Glycemic Control on Skeletal Outcomes in Adults With Type 1 Diabetes · enrolling by invitation
- NCT05859139 — Scaling a Decision Aid on Prenatal Screening for Trisomy 21, 18 and 13 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05176015 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CHU de Quebec-Universite Laval
- Last refreshed: 18 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05176015.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing